Navigation Links
Neuropathic pain: The sea provides a new hope of relief
Date:8/4/2009

ogy and Resources, National Sun Yat-Sen University, Taiwan.

Although the chemical they studied, capnellene, was originally isolated in 1974, it is only recently that scientists have started to appreciate its potential. Capnellene is interesting because its structure is very different from pain-relieving drugs currently in use. Initial experiments suggested that it may have pain-relieving properties. Working with Yen-Hsuan Jean MD, PhD and other colleagues, Dr Wen tested capnellene and a second very similar compound, in isolated microglial cells and in experimental models of the condition in rats.

They found that the compounds significantly reduced pain-related activities in isolated microglia, and that these compounds also significantly reversed hyperalgesic behaviour in the experimental rats.

"To provide better quality of life, we need new drugs that can act rapidly and have specific functions with low side effects. Moreover, we need better management for chronic pain conditions," says Dr Wen.

"Today there are few pharmacological agents that can help people suffering from neuropathic pain, but we believe that these marine-derived compounds could lead to the development of a new range of drugs of great potential," he adds.


'/>"/>

Contact: Jennifer Beal
medicalnews@wiley.com
44-124-377-0633
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related biology news :

1. I feel your pain: Neural mechanisms of empathy
2. UC San Diego engineer provides insights to decades-old DNA squabble
3. Study by NTU professors provides important insight into apoptosis or programmed cell death
4. Down Under dinosaur burrow discovery provides climate change clues
5. NSF provides $3.4 million to study climatically important Agulhas Current
6. Mouse model provides clues to human language development
7. Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution
8. A new mouse model provides insight into genetic neurological disorders
9. University of Florida study provides insight into evolution of first flowers
10. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
11. Songbird study from CSHL, CCNY provides concrete measure of biologys impact on culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... THE HAGUE, The Netherlands -- Recognizing the strategic ... and become recognized research leaders in the underwater ... Stevens Institute of Technology recently entered into an ... Memorandum of Understanding (MOU) between the university and ...
... moms abandon their eggs before they hatch doesn,t mean ... research in the American Naturalist shows that ... threats. Researchers Jonathan Storm of the University of ... Indiana State University placed pregnant crickets into enclosures containing ...
... Recovery and Reinvestment Act (ARRA) the economic stimulus ... examples of how a relatively small element of the ... the nation. Of the $787 billion contained in ... science infrastructure. ScienceWorksForUS, a coalition of three associations ...
Cached Biology News:Stevens and TNO to collaborate on maritime security 2Study: Crickets 'forewarn' unborn babies about spiders 2Universities highlight benefits of stimulus research funding 2Universities highlight benefits of stimulus research funding 3
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Visual Assay ... and celebrate the top 100 most innovative technologies and services of the past year. ... named in the Software/Services category. The winners will be announced at the 2015 R&D ...
(Date:7/24/2015)... , July 24, 2015 Ryan & Maniskas, ... in United States District Court for the Northern District of ... or entities that purchased the common stock of Avalanche Biotechnologies, ... July 31, 2014 and June 15, 2015, inclusive (the "Class ... 8, 2015, move the Court for appointment as a lead ...
(Date:7/24/2015)... -- Champions Oncology (OTC-BB: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year quarter ended April ... open. The company will host a conference ... a.m. EDT (6:00 a.m. PDT). To participate in the ...
(Date:7/24/2015)... The global next generation ... billion by 2022, growing at an estimated CAGR of ... study by Grand View Research, Inc. Development of faster, ... in significant reduction in cost of sequencing one base ... rates of next generation sequencing throughout the forecast period. ...
Breaking Biology Technology:Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... MISSISSAUGA, ON, Sept. 23 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... results for its fiscal year end, ended June 30, ... for YM. Our most notable development was the merger ... completed in January, from which we gained two important ...
... Resources, one of the world,s leading research and ... that growth in the leukemia market will be ... (Novartis,s Gleevec and Tasigna and Bristol-Myers Squibb,s Sprycel) ... Rituxan and Cephalon,s Treanda) until 2015, when patent ...
... 23 Dr. Paul Greengard, a Nobel Prize-winning ... Alzheimer,s Disease Research at The Rockefeller University, will ... September 23rd, 2010.  This medal is the highest ... anniversary celebrations, and recognizes the work of an ...
Cached Biology Technology:YM BioSciences reports fiscal year end 2010 operational and financial results 2YM BioSciences reports fiscal year end 2010 operational and financial results 3YM BioSciences reports fiscal year end 2010 operational and financial results 4YM BioSciences reports fiscal year end 2010 operational and financial results 5YM BioSciences reports fiscal year end 2010 operational and financial results 6YM BioSciences reports fiscal year end 2010 operational and financial results 7YM BioSciences reports fiscal year end 2010 operational and financial results 8YM BioSciences reports fiscal year end 2010 operational and financial results 9YM BioSciences reports fiscal year end 2010 operational and financial results 10YM BioSciences reports fiscal year end 2010 operational and financial results 11Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon 2Dr. Paul Greengard, Karolinska Institutet's Bicentennial Gold Medal Recipient 2
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
...
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Permeabilization Solution, 5X...
Biology Products: